To date, the Medicines Patent Pool has signed agreements with ten patent holders for 13 HIV antiretrovirals, one HIV technology platform, three hepatitis C direct-acting antivirals and a tuberculosis treatment.
Each quarter, we monitor the progress of our generic partners in developing, filing and selling MPP’s licensed medicines, in countries where access could not have been possible without our work.
Enabling access to affordable medicines for those who need them most, wherever they live, is MPP’s contribution to achieve Universal Health Coverage.
Hear from some of our partners on what they have to say about our work.
From sales of medicines to impact on peoples’ lives, the Medicines Patent Pool’s work is a game-changer in the access to treatments space.